The software titan is recruiting users to weigh in on how they want to interact with their own medical data, a report says.
Officials at CDC and FDA said they wanted to prepare healthcare providers to recognize and treat patients appropriately – and to report adverse events they may be seeing.
While provider customers were largely satisfied with their vendors' response to COVID-19, the report finds some major players stand out and others fall short.
The second phase of the company's Diagnostic Development Initiative will expand to include early disease detection, disease trajectory prognosis and public health genomics.
The Pittsburgh-based analytics firm will work with the federal government to provide public health officials with information through HHS Protect.
A new MIT study found label errors that could destabilize machine learning benchmarks.
At providers working closely with Castell, the cost of care for patients has decreased in a meaningful way, its chief analytics officer says.
The international platform is aimed at advancing and accelerating the transformation of healthcare supply chains through knowledge dissemination.
A healthcare revenue cycle management expert talks about the two technologies' impact on what can be a time-consuming and error-prone process.
The collaboration, focused on high-performance cloud computing and artificial intelligence for healthcare and life science research, will see an IBM 1,000-plus qubit system deployed in Cleveland.